Increasing glucose levels and BMI predict future heart failure. Experience from the Reykjavík Study

European Journal of Heart Failure

Volumn 9, Issue 10, 2007, Pages 1051-1057

  Thrainsdottir, I S ^a   Aspelund, T ^b   Gudnason, V ^b   Malmberg, K ^a   Sigurdsson, G ^b,c   Thorgeirsson, G ^b,c   Hardarson, T ^c   Ryden L ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b ICELANDIC HEART ASSOCIATION   (Iceland)

^c LANDSPITALI UNIVERSITY HOSPITAL   (Iceland)

Author keywords

Diabetes; Epidemiology; Heart failure; Incidence; Predictive factors

Indexed keywords

ADULT; AGED; ARTICLE; BODY MASS; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CONTROLLED STUDY; DIABETES MELLITUS; DISEASE ASSOCIATION; FEMALE; FOLLOW UP; GLUCOSE BLOOD LEVEL; GLYCEMIC INDEX; HEART FAILURE; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; ORAL GLUCOSE TOLERANCE TEST; PREDICTOR VARIABLE; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR;

ADULT; AGED; AGED, 80 AND OVER; BLOOD GLUCOSE; BODY MASS INDEX; CARDIOVASCULAR DISEASES; DISEASE PROGRESSION; FASTING; FEMALE; GLUCOSE TOLERANCE TEST; HEART FAILURE; HUMANS; HYPERGLYCEMIA; ICELAND; INCIDENCE; MALE; MIDDLE AGED; PROGNOSIS; PROSPECTIVE STUDIES; RISK FACTORS;

EID: 34648825998     PISSN: 13889842     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejheart.2007.07.017     Document Type: Article

References (27)

1. Coutinho M., Gerstein H.C., Wang Y., and Yusuf S. The relationship between glucose and incident cardiovascular events. A metaregression analysis of published data from 20 studies of 95,783 individuals followed for 12.4 years. Diabetes Care 22 (1999) 233-240
2. Karvounis H.I., Papadopoulos C.E., Zaglavara T.A., et al. Evidence of left ventricular dysfunction in asymptomatic elderly patients with non-insulin-dependent diabetes mellitus. Angiology 55 (2004) 549-555
3. Lundbæk K. Diabetic angiopathy. A specific vascular disease. Lancet 20 (1954) 377-379
4. Thrainsdottir I.S., Aspelund T., Thorgeirsson G., et al. The association between glucose abnormalities and heart failure in the population based Reykjavík Study. Diabetes Care 28 (2005) 612-616
5. Bertoni A.G., Hundley W.G., Massing M.W., Bonds D.E., Burke G.L., and Goff D.C. Heart failure prevalence, incidence and mortality in the elderly with diabetes. Diabetes Care 27 (2004) 699-703
6. Thrainsdottir I.S., Aspelund T., Hardarson T., et al. Glucose abnormalities and heart failure predict poor prognosis in the population based Reykjavík Study. Eur J Cardiovasc Prev Rehabil 12 (2005) 465-471
7. Amato L., Paolisso G., Cacciatore F., et al. Congestive heart failure predicts the development of non-insulin-dependent diabetes mellitus in the elderly. Diabete Metab 23 (1997) 213-218
8. Thrainsdottir I.S., Hardarson T., Thorgeirsson G., Sigvaldason H., and Sigfusson N. The epidemiology of right bundle branch block and its association with cardiovascular morbidity - The Reykjavik Study. Eur Heart J 14 (1993) 1590-1596
9. Vilbergsson S., Sigurdsson G., Sigvaldason H., Hreidarsson Á.B., and Sigfusson N. Prevalence and incidence of NIDDM in Iceland: Evidence for stable incidence among males and females 1967-1991 - The Reykjavík Study. Diabet Med 14 (1997) 491-498
10. Björnsson OJ, Davidsson D, Ólafsson Ó, Sigfússon N, Thorsteinsson Th. Report ABC XVIII. Health survey in the Reykjavik area. Males. Stages I-II, 1967-8, 1970-71 and 1976-78. Participants, invitations, etc, Hjartavernd. Reykjavík 1979.
11. Remme W.J., Swedberg K., Task Force for the Diagnosis and Treatment of Chronic Heart Failure, and European Society of Cardiology. Guidelines for the diagnosis and treatment of chronic heart failure. Eur Heart J 22 (2001) 1527-1560
12. WHO MONICA project, MONICA Manual, revised edition. Geneva, WHO, Cardiovascular disease unit, 1980.
13. Sorlie P.D., Cooper L., Schreiner P.J., Rosamond W., and Szklo M. Repeatability and validity of the Rose questionnaire for angina pectoris in the atherosclerosis risk in Communities Study. J Clin Epidemiol 49 (1996) 719-725
14. Korn E.L., Graubard B.I., and Midthune D. Time-to-event analysis of longitudinal follow-up of a survey: choice of the time-scale. Am J Epidemiol 145 (1997) 72-80
15. Thiébaut A.C.M., and Bénichou J. Choice of time-scale in Cox's model analysis of epidemiologic cohort data: a simulation study. Stat Med 23 (2004) 3803-3820
16. SAS Institute Inc. SAS OnlineDoc®, Version 8 (2000), SAS Institute Inc., Cary, NC
17. Aspelund T., Thorgeirsson G., Sigurdsson G., and Gudnason V. Estimation of ten year risk of fatal cardiovascular disease in Iceland: a comparison with the SCORE project. Eur Heart J 27 (2005) 44 [Abstr Suppl]
18. Eriksson H., Svarsudd K., Larsson B., et al. Risk factors for heart failure in the general population: the study of men born in 1913. Eur Heart J 10 (1989) 647-656
19. Remes J., Reuanen A., Aromaa A., and Pyorala K. Incidence of heart failure in eastern Finland: a population-based surveillance study. Eur Heart J 13 (1992) 588-593
20. Kannel W.B., and Belanger A.J. Epidemiology of heart failure. Am Heart J 121 (1991) 951-957
21. Bleumink G.S., Knetsch A.M., Sturkenboom M.C., et al. Quantifying the heart failure epidemic: prevalence, incidence rate, lifetime risk and prognosis of heart failure. The Rotterdam Study. Eur Heart J 25 (2004) 1614-1619
22. Ubink-Veltmaat L.J., Bilo H.J.G., Groenier K.H., Houweling S.T., Rischen R.O., and Meyboom-de Jong B. Prevalence, incidence and mortality of type 2 diabetes mellitus revisited: a prospective population-based study in The Netherlands (ZODIAC-1). Eur J Epidemiol 18 (2003) 793-800
23. Andersson D.K., Svardsudd K., and Tibblin G. Prevalence and incidence of diabetes in a Swedish community 1972-1987. Diabet Med 8 (1991) 428-434
24. Ingelsson E., Arnlov J., Lind L., and Sundstrom J. Metabolic syndrome and risk for heart failure in middle-aged men. Heart 92 (2006) 1409-1413
25. Ingelsson E., Sundstrom J., Arnlov J., Zethelius B., and Lind L. Insulin resistance and risk of congestive heart failure. JAMA 294 (2005) 334-341
26. Nichols G.A., Gullion C.M., Koro C.E., Ephross S.A., and Brown J.B. The incidence of congestive heart failure in type 2 diabetes. Diabetes Care 27 (2004) 1879-1884
27. Rydén L., Standl E., Bartnik M., et al. Guidelines on diabetes, pre-diabetes, and cardiovascular diseases: executive summary: The Task Force on Diabetes and Cardiovascular Diseases of the European Society of Cardiology (ESC) and of the European Association for the Study of Diabetes (EASD). Eur Heart J 28 (2007) 88-136